JP2020521440A - Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出 - Google Patents

Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出 Download PDF

Info

Publication number
JP2020521440A
JP2020521440A JP2019559727A JP2019559727A JP2020521440A JP 2020521440 A JP2020521440 A JP 2020521440A JP 2019559727 A JP2019559727 A JP 2019559727A JP 2019559727 A JP2019559727 A JP 2019559727A JP 2020521440 A JP2020521440 A JP 2020521440A
Authority
JP
Japan
Prior art keywords
exon
alk
ros1
ret
fusion gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019559727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020521440A5 (enExample
Inventor
ベゴビック アン
ベゴビック アン
チュン シンディー
チュン シンディー
チー ジャベリン
チー ジャベリン
ヒルマン グラントランド
ヒルマン グラントランド
クオ ドワイト
クオ ドワイト
マイケル　リー
リー マイケル
マックス マー シアオチュイ
マックス マー シアオチュイ
マノハー チトラ
マノハー チトラ
オーディナリオ エレン
オーディナリオ エレン
ラジャマニ ジャヤ
ラジャマニ ジャヤ
チュオン フアン
チュオン フアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62567625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2020521440(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2020521440A publication Critical patent/JP2020521440A/ja
Publication of JP2020521440A5 publication Critical patent/JP2020521440A5/ja
Priority to JP2023206878A priority Critical patent/JP2024019433A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2019559727A 2017-05-31 2018-05-30 Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出 Pending JP2020521440A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023206878A JP2024019433A (ja) 2017-05-31 2023-12-07 Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762513226P 2017-05-31 2017-05-31
US62/513,226 2017-05-31
PCT/EP2018/064172 WO2018220004A1 (en) 2017-05-31 2018-05-30 Multiplex pcr detection of alk, ret, and ros fusions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023206878A Division JP2024019433A (ja) 2017-05-31 2023-12-07 Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出

Publications (2)

Publication Number Publication Date
JP2020521440A true JP2020521440A (ja) 2020-07-27
JP2020521440A5 JP2020521440A5 (enExample) 2021-07-26

Family

ID=62567625

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019559727A Pending JP2020521440A (ja) 2017-05-31 2018-05-30 Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出
JP2023206878A Pending JP2024019433A (ja) 2017-05-31 2023-12-07 Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023206878A Pending JP2024019433A (ja) 2017-05-31 2023-12-07 Ａｌｋ、ｒｅｔ、およびｒｏｓ融合の多重ｐｃｒ検出

Country Status (8)

Country Link
US (2) US11505830B2 (enExample)
EP (1) EP3631011B1 (enExample)
JP (2) JP2020521440A (enExample)
CN (1) CN110691852A (enExample)
AU (1) AU2018277210B2 (enExample)
CA (1) CA3059119C (enExample)
ES (1) ES2883934T3 (enExample)
WO (1) WO2018220004A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3631011B1 (en) 2017-05-31 2021-06-23 Roche Diagnostics GmbH Multiplex pcr detection of alk, ret, and ros fusions
CN109837275B (zh) * 2019-01-08 2022-09-06 大连医科大学附属第二医院 一种融合基因阳性对照标准品的制备方法
CN111718994A (zh) * 2019-03-22 2020-09-29 广州金域医学检验中心有限公司 肿瘤融合基因靶向检测探针、试剂盒及应用
CN110964830A (zh) * 2019-12-31 2020-04-07 中山大学达安基因股份有限公司 多重检测ros1基因突变的试剂盒及方法
CN112029857B (zh) * 2020-08-14 2026-03-24 上海真固生物科技有限公司 一种引物组合物及用于融合基因检测的试剂
CN115466788B (zh) * 2022-06-28 2026-02-10 湖南圣洲生物科技有限公司 引物探针组合、试剂盒及其检测人alk、ros1基因融合的方法
CN117144016A (zh) * 2023-10-27 2023-12-01 神州医疗科技股份有限公司 一种用于外周血循环肿瘤rna中检测ret融合基因的引物探针、试剂盒及检测系统

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535812A (ja) * 1999-02-18 2003-12-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発光マーカーとして用いるためのサリチルアミド−ランタニド錯体
JP2004516806A (ja) * 2000-04-05 2004-06-10 モレキュラー ステージング，インコーポレイテッド プライマー伸長法を用いた対立遺伝子識別のためのプロセス
JP2007525184A (ja) * 2003-04-30 2007-09-06 ピーエイチアールアイ プロパティーズ，インコーポレイテッド 均一マルチプレックススクリーニングアッセイおよびキット
WO2011162295A1 (ja) * 2010-06-22 2011-12-29 アステラス製薬株式会社 新規ｒｏｓ１融合体の検出法
JP2013502931A (ja) * 2009-08-28 2013-01-31 アスラジェン， インコーポレイテッド 肺疾患のｍｉＲＮＡバイオマーカー
WO2015164869A1 (en) * 2014-04-25 2015-10-29 Exelixis, Inc. Method of treating lung adenocarcinoma
JP2016515380A (ja) * 2013-03-15 2016-05-30 ライフ テクノロジーズ コーポレーション 肺癌の分類及び実施可能性インデックス
US20160304937A1 (en) * 2015-04-17 2016-10-20 Roche Molecular Systems, Inc. Multiplex pcr to detect gene fusions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455170A (en) 1986-08-22 1995-10-03 Hoffmann-La Roche Inc. Mutated thermostable nucleic acid polymerase enzyme from Thermus species Z05
PL2450437T3 (pl) * 2006-04-14 2017-12-29 Cell Signaling Technology Inc Defekty genu i zmutowana kinaza ALK w ludzkich guzach litych
WO2008127248A1 (en) * 2007-04-13 2008-10-23 Cell Signaling Technology, Inc. Gene defects and mutant alk kinase in human solid tumors
JPWO2012014795A1 (ja) * 2010-07-26 2013-09-12 アステラス製薬株式会社 新規ｒｅｔ融合体の検出法
US20130059762A1 (en) * 2011-04-28 2013-03-07 Life Technologies Corporation Methods and compositions for multiplex pcr
US20130237442A1 (en) * 2012-03-07 2013-09-12 University Of Miami Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy
CA2902167A1 (en) 2013-03-15 2014-09-25 Abbott Molecular Inc. Method for amplification and assay of rna fusion gene variants, method of distinguishing same and related primers, probes, and kits
US10072298B2 (en) 2013-04-17 2018-09-11 Life Technologies Corporation Gene fusions and gene variants associated with cancer
WO2015148494A1 (en) 2014-03-25 2015-10-01 Quest Diagnostics Investments Incorporated Detection of gene fusions by intragenic differential expression (ide) using average cycle thresholds
CN106414768B (zh) 2014-03-27 2020-05-29 生命技术公司 与癌症相关的基因融合体和基因变异体
CN104818320B (zh) * 2014-12-03 2018-02-06 厦门艾德生物医药科技有限公司 一次性检测肺癌多重基因的引物、探针、检测体系和试剂盒
EP3631011B1 (en) 2017-05-31 2021-06-23 Roche Diagnostics GmbH Multiplex pcr detection of alk, ret, and ros fusions

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535812A (ja) * 1999-02-18 2003-12-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発光マーカーとして用いるためのサリチルアミド−ランタニド錯体
JP2004516806A (ja) * 2000-04-05 2004-06-10 モレキュラー ステージング，インコーポレイテッド プライマー伸長法を用いた対立遺伝子識別のためのプロセス
JP2007525184A (ja) * 2003-04-30 2007-09-06 ピーエイチアールアイ プロパティーズ，インコーポレイテッド 均一マルチプレックススクリーニングアッセイおよびキット
JP2013502931A (ja) * 2009-08-28 2013-01-31 アスラジェン， インコーポレイテッド 肺疾患のｍｉＲＮＡバイオマーカー
WO2011162295A1 (ja) * 2010-06-22 2011-12-29 アステラス製薬株式会社 新規ｒｏｓ１融合体の検出法
JP2016515380A (ja) * 2013-03-15 2016-05-30 ライフ テクノロジーズ コーポレーション 肺癌の分類及び実施可能性インデックス
WO2015164869A1 (en) * 2014-04-25 2015-10-29 Exelixis, Inc. Method of treating lung adenocarcinoma
US20160304937A1 (en) * 2015-04-17 2016-10-20 Roche Molecular Systems, Inc. Multiplex pcr to detect gene fusions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing", THE JOURNAL OF MOLECULAR DIAGNOSTICS, vol. Volume 18, Number 2, JPN6022011971, 2016, pages 165 - 175, ISSN: 0004965122 *
"Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-F", JOURNAL OF THORACIC ONCOLOGY, vol. Volume 11, Number 2, JPN6022011972, 2015, pages 203 - 212, ISSN: 0004965123 *

Also Published As

Publication number Publication date
WO2018220004A1 (en) 2018-12-06
US20230121541A1 (en) 2023-04-20
CN110691852A (zh) 2020-01-14
AU2018277210A1 (en) 2019-10-17
CA3059119A1 (en) 2018-12-06
CA3059119C (en) 2024-01-23
AU2018277210B2 (en) 2024-03-28
ES2883934T3 (es) 2021-12-09
US20180346994A1 (en) 2018-12-06
US11505830B2 (en) 2022-11-22
EP3631011A1 (en) 2020-04-08
JP2024019433A (ja) 2024-02-09
EP3631011B1 (en) 2021-06-23

Similar Documents

Publication Publication Date Title
EP3283645B1 (en) Multiplex pcr to detect gene fusions
US20230121541A1 (en) Multiplex pcr detection of alk, ret, and ros fusions
US11965212B2 (en) Nucleic acid detection combining amplification with fragmentation
JP2022137291A (ja) 核酸配列変種を検出するための方法
JP2016506748A (ja) 高い選択性の核酸増幅プライマー
CN103459612A (zh) 用于检测野生型群体中的核酸突变体的方法和试剂盒
US20190256925A1 (en) Detection of microsatellite instability
Wang et al. DNA degradation test predicts success in whole-genome amplification from diverse clinical samples
CN109072293A (zh) Met外显子14缺失的检测和相关疗法
US20120045747A1 (en) Kit for detecting hepatitis b virus and method for detecting hepatitis b virus using the same
US20120052482A1 (en) Kit for detecting hepatitis c virus and method of detecting hepatitis c virus using the same
JP2003518951A (ja) 多型核酸配列の同時増幅およびリアルタイム検出のための方法
US20150184250A1 (en) Kras primers and probes
US10597725B2 (en) Primer reagent for amplifying ALK fusion gene, ALK fusion gene amplification reagent kit including the same, and ALK fusion gene amplification method and ALK fusion gene analysis method using the same
KR102321902B1 (ko) Braf 돌연변이 검출을 위한 dna 중합효소 및 이를 포함하는 키트
JP7392270B2 (ja) Ｉｄｈ－１遺伝子多型の検出方法
WO2011077990A1 (ja) ｃ－ｋｉｔ遺伝子の多型検出用プローブおよびその用途
EP2418289B1 (en) Method of distinguishing genotypes
KR20190038464A (ko) Ras/braf 돌연변이 검출용 조성물 및 이를 포함하는 키트
JP6533128B2 (ja) Ａｌｋ融合遺伝子を増幅するためのプライマー試薬、それを含むａｌｋ融合遺伝子の増幅試薬キット、それを用いたａｌｋ融合遺伝子の増幅方法および分析方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210528

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210528

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220329

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220330

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230714

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231207

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240118

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20240322